High-Intensity Functional Training (HIFT) vs Moderate-Intensity Continuous Training (MICT) in College Students
The Effects of Interval Compared to Continuous Training on Physical Variables and Vascular Health in College Students: A Three-Arm Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
The purpose of this study is to compare two types of exercise programs in college students: high-intensity functional training and moderate-intensity continuous training. The study evaluates whether these exercise programs improve body composition, physical fitness, and blood vessel health compared with a group that does not participate in exercise training. In addition, the study examines whether changes in body composition and physical fitness are associated with changes in blood vessel health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2026
CompletedFirst Posted
Study publicly available on registry
August 4, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
Study Completion
Last participant's last visit for all outcomes
June 1, 2028
August 4, 2026
June 1, 2026
1.8 years
July 15, 2026
July 29, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Change in Carotid-Femoral Pulse Wave Velocity (cfPWV)
Carotid-femoral pulse wave velocity (cfPWV) will be measured in meters per second (m/s) at baseline and post intervention as an indicator of arterial stiffness. Measurement will be obtained using the SphygmoCor XCEL device (AtCor Medical) with upper arm and thigh cuffs with carotid artery applanation tonometry to assess pulse wave transit time
Baseline and Week 10 (post-intervention)
Change in Central Augmentation Index (cAIx)
The central augmentation index (cAIx), expressed as a percentage, will be assessed at baseline and post-intervention using the SphygmoCor XCEL device via pulse wave analysis of the central arterial waveform derived from carotid artery tonometry and peripheral blood pressure measurements.
Baseline and Week 10 (post-intervention)
Change in Mean Arterial Pressure (MAP)
Mean arterial pressure (MAP), measured in millimeters of mercury (mmHg), will be assessed at baseline and post-intervention. MAP will be assessed using the SphygmoCor XCEL system (AtCor Medical) based on an algorithm derived from peripheral blood pressure obtained via an automated upper arm cuff.
Baseline and Week 10 (post-intervention)
Percent Change in Flow-Mediated Dilation (FMD)
Flow-Mediated Dilation (FMD) will be measured at baseline and post-intervention using a Philips Affiniti 50 ultrasound system and expressed as the percent (%) change in brachial artery diameter from pre-occlusion baseline to peak dilation following a 5-minute forearm occlusion. The outcome will be reported as the change in FMD (%) from baseline to post-intervention.
Baseline and Week 10 (post-intervention)
Change in Carotid Intima-Media Thickness (cIMT)
Carotid intima-media thickness (cIMT), measured in millimeters (mm), will be assessed using a Philips Affiniti 50 ultrasound system at baseline and post-intervention. High-resolution B-mode images of the distal common carotid artery will be acquired, and mean wall thickness will be calculated from standardized image segments of the left and right carotid arteries.
Baseline and Week 10 (post-intervention)
Secondary Outcomes (10)
Change in Body mass index (BMI)
Baseline and Week 10 (post-intervention)
Change in Waist Circumference (WC)
Baseline and 10 weeks (post-intervention)
Change in Body fat percentage (BF%)
Baseline and 10 weeks (post-intervention)
Change in Skeletal Muscle Mass (SMM)
Baseline and 10 weeks (post-intervention)
Change in visceral adipose tissue (VAT)
Baseline and 10 weeks (post-intervention)
- +5 more secondary outcomes
Study Arms (3)
High-intensity Functional Training (HIFT) Group
EXPERIMENTALParticipants in this group will perform supervised high-intensity functional training (HIFT) using multi-joint functional movements. Participants will complete training 3 days per week for 8 weeks.
Moderate-intensity Continuous Training (MICT) Group
EXPERIMENTALParticipants in this group will perform supervised moderate-intensity continuous aerobic exercise. Participants will complete training 3 days per week for 8 weeks.
Control Group
NO INTERVENTIONThe control group will not receive supervised exercise training during the intervention period.
Interventions
Participants will perform supervised high-intensity functional training using multi-joint functional movements that may include body-weight exercises, resistance-based movements, step-ups, squats, lunges, push-ups or modified push-ups, core exercises, etc. The intervention will be conducted over 8 weeks, with participants completing three sessions per week. Each session will last approximately 40 to 60 minutes.
Participants will perform supervised moderate-intensity continuous aerobic exercise such as treadmill walking/jogging, cycling, elliptical exercise, or step-based aerobic activity. The intervention will be conducted over 8 weeks, with participants completing three sessions per week. Each session will last approximately 40 to 60 minutes.
Eligibility Criteria
You may qualify if:
- Age 18 to 35 years.
- Currently enrolled college or university student.
- Able to provide written informed consent.
- Able to attend baseline and post-intervention testing visits and participate in assigned intervention sessions.
- Cleared for exercise participation based on the health screening form and investigator review.
You may not qualify if:
- Known cardiovascular, metabolic, pulmonary, renal, neurological, musculoskeletal, or endocrine disorder that would make exercise unsafe or confound outcome measures.
- Current pregnancy or planning pregnancy during the study period.
- Current smoking, vaping nicotine products, or use of tobacco products.
- Uncontrolled hypertension or resting blood pressure values that make exercise testing unsafe based on investigator judgment.
- Use of medications known to substantially affect cardiovascular function, vascular tone, or exercise responses, unless approved by the PI.
- Any injury, orthopedic limitation, or medical condition preventing safe participation in HIFT, MICT, or physical fitness testing.
- Currently participating in structured high-intensity interval, functional, or endurance training more than two days per week during the previous three months.
- Do not speak English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Merrick Building, University of Miami
Coral Gables, Florida, 33146, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arlette Perry, PhD
University of Miami
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 15, 2026
First Posted
August 4, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
June 1, 2028
Last Updated
August 4, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share